Healthcare Sector Insider Trading Activity

Track insider buying and selling in Healthcare stocks. See which executives are buying, net insider activity, and % of float traded across 3,445 companies.
The information provided in this screen is for informational purposes only and does not constitute financial advice. We do not endorse any specific investment based on these criteria.
Companies
Data
Subscribe to access full data
Company Business Sector Market cap ($) # net buying insiders Net value bought ($) % of float bought % of shares held by insiders
Pharmaceuticals & Medical Research Large (17.2bn) -1–5 -$100K–$1M -0–15% 0–15%
US ABIOMED Inc (ABMD)
Healthcare Services Large (17.2bn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Large (17.1bn) 0 No activity — 0–15%
US Hologic Inc (HOLX)
Healthcare Services Large (16.9bn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Large (16.7bn) 0 No activity — 0–15%
DK Coloplast A/S (COLO-B)
Healthcare Services Large (16.0bn) 0 No activity — 15–50%
IN Cipla Ltd (CIPLA)
Pharmaceuticals & Medical Research Large (15.9bn) 0 No activity — 15–50%
Healthcare Services Large (15.6bn) 0 No activity — 15–50%
Pharmaceuticals & Medical Research Large (15.6bn) -1–5 -$10M–$100M -0–15% 0–15%
IE ICON PLC (ICLR)
Pharmaceuticals & Medical Research Large (14.6bn) -6–10 -$1M–$10M -0–15% 0–15%
Pharmaceuticals & Medical Research Large (14.2bn) 0 No activity — 15–50%
Pharmaceuticals & Medical Research Large (14.0bn) 0 No activity — 0–15%
FR Ipsen SA (IPN)
Pharmaceuticals & Medical Research Large (14.0bn) 1–5 $100K–$1M 0–15% 50%+
Healthcare Services Large (13.9bn) -1–5 -$1M–$10M -0–15% 0–15%
Healthcare Services Large (13.8bn) -1–5 -$10M–$100M -0–15% 0–15%
Pharmaceuticals & Medical Research Large (13.5bn) 0 No activity — 0–15%
Healthcare Services Large (13.5bn) 0 No activity — 15–50%
Healthcare Services Large (13.2bn) 0 No activity — 15–50%
Pharmaceuticals & Medical Research Large (13.2bn) 0 No activity — 50%+
Pharmaceuticals & Medical Research Large (13.1bn) 0 No activity — 50%+
FI Orion Oyj (ORNBV)
Pharmaceuticals & Medical Research Large (13.0bn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Large (12.9bn) 0 No activity — 50%+
Healthcare Services Large (12.6bn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Large (12.6bn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Large (12.3bn) -1–5 -$10M–$100M -0–15% 15–50%
Healthcare Services Large (12.2bn) 0 No activity — 0–15%
Healthcare Services Large (12.2bn) -1–5 -$1M–$10M -0–15% 0–15%
Pharmaceuticals & Medical Research Large (12.0bn) 0 No activity — 0–15%
DK Demant A/S (DEMANT)
Healthcare Services Large (11.9bn) 0 No activity — 50%+
Pharmaceuticals & Medical Research Large (11.9bn) 0 No activity — 15–50%
Healthcare Services Large (11.7bn) -1–5 -$100K–$1M -0–15% 0–15%
Healthcare Services Large (11.6bn) 0 No activity — 15–50%
Pharmaceuticals & Medical Research Large (11.5bn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Large (11.4bn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Large (11.4bn) 0 No activity — 0–15%
Healthcare Services Large (11.3bn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Large (11.3bn) -1–5 -$1M–$10M -0–15% 0–15%
Pharmaceuticals & Medical Research Large (11.3bn) 0 No activity — 50%+
Pharmaceuticals & Medical Research Large (11.3bn) 1–5 $100K–$1M 0–15% 0–15%
Pharmaceuticals & Medical Research Large (11.2bn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Large (11.2bn) -1–5 -$100K–$1M -0–15% 0–15%
Pharmaceuticals & Medical Research Large (11.0bn) 0 No activity — 15–50%
Healthcare Services Large (11.0bn) -1–5 -$10M–$100M -0–15% 15–50%
Pharmaceuticals & Medical Research Large (10.9bn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Large (10.9bn) 0 No activity — 50%+
Healthcare Services Large (10.9bn) 0 No activity — 0–15%
Healthcare Services Large (10.9bn) 1–5 -< $100K -0–15% 0–15%
Healthcare Services Large (10.7bn) 0 No activity — 0–15%
Healthcare Services Large (10.7bn) -1–5 -$1M–$10M -0–15% 0–15%
Healthcare Services Large (10.6bn) 0 No activity — 0–15%
Healthcare Services Large (10.5bn) 1–5 $1M–$10M 0–15% 0–15%
Pharmaceuticals & Medical Research Large (10.3bn) 0 No activity — 0–15%
Healthcare Services Large (10.3bn) -1–5 -$1M–$10M -0–15% 15–50%
Pharmaceuticals & Medical Research Large (10.2bn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Large (10.2bn) 0 No activity — 0–15%
Healthcare Services Large (10.1bn) 0 No activity — 0–15%
Healthcare Services Mid (10.0bn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Mid (9.8bn) 0 No activity — 0–15%
US Vaxcyte Inc (PCVX)
Pharmaceuticals & Medical Research Mid (9.8bn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Mid (9.7bn) -1–5 -$100K–$1M -0–15% 0–15%
Pharmaceuticals & Medical Research Mid (9.6bn) 0 No activity — 15–50%
Healthcare Services Mid (9.5bn) -1–5 -$10M–$100M -0–15% 15–50%
US Masimo Corp (MASI)
Healthcare Services Mid (9.4bn) 0 No activity — 0–15%
Healthcare Services Mid (9.4bn) 0 No activity — 15–50%
Pharmaceuticals & Medical Research Mid (9.3bn) 0 $10M–$100M 0–15% 0–15%
Pharmaceuticals & Medical Research Mid (9.1bn) 0 No activity — 0–15%
Healthcare Services Mid (9.1bn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Mid (9.1bn) -1–5 -$10M–$100M -0–15% 0–15%
Pharmaceuticals & Medical Research Mid (9.0bn) 0 No activity — 0–15%
Healthcare Services Mid (8.9bn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Mid (8.7bn) 0 No activity — 0–15%
US Mylan NV (MYL)
Pharmaceuticals & Medical Research Mid (8.6bn) 0 No activity — 0–15%
DK H Lundbeck A/S (HLUN-A)
Pharmaceuticals & Medical Research Mid (8.5bn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Mid (8.4bn) 0 No activity — 0–15%
FR Abivax SA (ABVX)
Pharmaceuticals & Medical Research Mid (8.3bn) -1–5 -$100K–$1M -0–15% 0–15%
Pharmaceuticals & Medical Research Mid (8.2bn) -1–5 -$1M–$10M -0–15% 0–15%
Pharmaceuticals & Medical Research Mid (8.1bn) -1–5 -$1M–$10M -0–15% 0–15%
Pharmaceuticals & Medical Research Mid (8.1bn) -1–5 -$10M–$100M -0–15% 0–15%
Pharmaceuticals & Medical Research Mid (8.0bn) 0 No activity — 0–15%
SE Getinge AB (GETI-B)
Healthcare Services Mid (7.8bn) 0 No activity — 15–50%
Healthcare Services Mid (7.8bn) 0 No activity — 50%+
Pharmaceuticals & Medical Research Mid (7.8bn) 0 No activity — 15–50%
Pharmaceuticals & Medical Research Mid (7.7bn) 0 No activity — 15–50%
Pharmaceuticals & Medical Research Mid (7.7bn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Mid (7.5bn) 0 No activity — 0–15%
Healthcare Services Mid (7.5bn) -1–5 -$1M–$10M -0–15% 50%+
IN Aurobindo Pharma Ltd (AUROPHARMA)
Pharmaceuticals & Medical Research Mid (7.4bn) 0 No activity — 50%+
Pharmaceuticals & Medical Research Mid (7.4bn) -1–5 -$10M–$100M -0–15% 0–15%
Pharmaceuticals & Medical Research Mid (7.4bn) -6–10 -$10M–$100M -0–15% 0–15%
Pharmaceuticals & Medical Research Mid (7.4bn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Mid (7.1bn) -1–5 -$100K–$1M -0–15% 0–15%
Healthcare Services Mid (7.1bn) 0 No activity — 0–15%
Healthcare Services Mid (7.1bn) -1–5 -$1M–$10M -0–15% 0–15%
Pharmaceuticals & Medical Research Mid (7.1bn) 0 No activity — 50%+
Pharmaceuticals & Medical Research Mid (7.1bn) -1–5 -$100K–$1M -0–15% 50%+
Healthcare Services Mid (7.0bn) 1–5 $100M+ 0–15% 50%+
Pharmaceuticals & Medical Research Mid (7.0bn) 0 No activity — 0–15%
US Merus NV (MRUS)
Pharmaceuticals & Medical Research Mid (6.8bn) 0 No activity — 50%+
NL Qiagen NV (QIA)
Pharmaceuticals & Medical Research Mid (6.8bn) 0 No activity — 0–15%
Healthcare Services Mid (6.8bn) -1–5 -$1M–$10M -0–15% 50%+
Loading...